The world-leading team at Synchronicity Pharma is developing groundbreaking cancer therapies from pioneering insights into cancer’s dependence on clock function.

Synchronicity Pharma has developed the first ever clinical stage compound shown to safely target the core-clock molecular machinery and to modulate clock-regulated gene expression in humans.